Diablo Valley Oncology Hematology Medical Group — Pleasant Hill, California

Diablo Valley Oncology Hematology Medical Group is a clinical research site located in Pleasant Hill, California, United States 94523.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Diablo Valley Oncology Hematology Medical Group has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Advanced Breast Cancer, Metastatic Breast Cancer, Invasive Ductal Carcinoma.

Sponsors: Pfizer, Xoft, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Pleasant Hill

Browse all research sites in California · View every site in Pleasant Hill

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Diablo Valley Oncology Hematology Medical Group?

Diablo Valley Oncology Hematology Medical Group has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Diablo Valley Oncology Hematology Medical Group conducted?

Diablo Valley Oncology Hematology Medical Group has 2 clinical trials on record, with 1 currently active. Their work covers Advanced Breast Cancer, Metastatic Breast Cancer, Invasive Ductal Carcinoma.

Is Diablo Valley Oncology Hematology Medical Group accredited by Crixeo Clinical Trials?

Diablo Valley Oncology Hematology Medical Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Diablo Valley Oncology Hematology Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.